![Derek Lindsay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Derek Lindsay
Directeur Général chez Redx Oncology Ltd.
Provenance du réseau au premier degré de Derek Lindsay
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 15 | |
Nhs Ayrshire & Arran
![]() Nhs Ayrshire & Arran Hospital/Nursing ManagementHealth Services NHS Ayrshire & Arran is a healthcare provider that offers a wide range of high-quality health services to a population of approximately 367,000 people. NHS Ayrshire & Arran also has a duty to protect public health throughout Ayrshire and Arran. The private company is based in Ayrshire, UK, and has subsidiaries in the United Kingdom. The British company has invested in modern hospitals and community facilities, and its highly trained and qualified staff provide healthcare services. The CEO of the company is Claire Burden.
15
| Private Company | Hospital/Nursing Management | 15 |
Infex Therapeutics Ltd.
![]() Infex Therapeutics Ltd. BiotechnologyHealth Technology AMR Centre Ltd. is a British biotechnology research company founded in 2016. The private company is based in Cheshire, UK. The company conducts research in the field of biotechnology.
4
| Private Company | Biotechnology | 4 |
Redx Oncology Ltd.
![]() Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Derek Lindsay via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Public Communications Contact | |
Acambis Plc
![]() Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Biotechnology | Director of Finance/CFO | |
Seqirus Vaccines Ltd.
![]() Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Biotechnology | Director of Finance/CFO | |
RENEURON GROUP PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Ambicare Health Ltd.
![]() Ambicare Health Ltd. Medical SpecialtiesHealth Technology Ambicare Health Ltd. manufactures medical products for skin care. The firm develops and commercializes proprietary, light emitting diode (LED) based devices for the treatment skin conditions and diseases. Its ambulatory lighting products offer solutions incorporating OLED (Organic Light Emitting Diode) and LED (Light Emitting Diode) technologies. The products offer battery operated flexible packaged solutions with high light uniformity. The company was founded by James Ferguson and Ifor Samuel in 2004 and is headquartered in Livingston, the United Kingdom. | Medical Specialties | Chairman | |
GSK PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
Powderject Pharmaceuticals Plc
![]() Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member | |
Institut Pasteur
![]() Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Institute of Chartered Accountants in England & Wales
![]() Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Carroll London Markets Ltd.
![]() Carroll London Markets Ltd. Insurance Brokers/ServicesFinance Carroll Mondon Markets Ltd. provides insurance brokerage services. It offers broking services in the areas of motor fleet, private clients/high-mid net worth, and third party binders. The company was founded in 1832 and is headquartered in London, the United Kingdom. | Insurance Brokers/Services | Director/Board Member | |
Gardant Pharmaceuticals, Inc.
![]() Gardant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gardant Pharmaceuticals, Inc. develops and commercializes pharmaceutical compounds. It develops network for research, clinical development, and project management and guides them through the clinical development and licensing stages. The company was founded in 2000 and is headquartered in New York, NY | Pharmaceuticals: Major | Chief Executive Officer | |
The Rockefeller University | College/University | Corporate Officer/Principal | |
University of Leiden | College/University | Corporate Officer/Principal | |
University of Utrecht | College/University | Doctorate Degree | |
University of Paisley | College/University | Undergraduate Degree | |
Sanofi-Aventis Deutschland GmbH
![]() Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Universität Konstanz | College/University | Doctorate Degree | |
University of Helsinki | College/University | Graduate Degree | |
Arthur Andersen (UK)
![]() Arthur Andersen (UK) Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Arthur Andersen (UK) is a British company that provides accounting services. The company is based in Reading, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Merck Serono SA
![]() Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
VocaLink Ltd.
![]() VocaLink Ltd. Regional BanksFinance VocaLink Ltd. provides electronic financial payment services. Its services include payment processing, access services, banking services, international, and mobile payments. The company was founded in 1968 and is headquartered in Rickmansworth, the United Kingdom. | Regional Banks | Chairman | |
King's College London | College/University | Graduate Degree | |
The University of Law Ltd. | College/University | Graduate Degree Graduate Degree | |
Vascular Flow Technologies Ltd.
![]() Vascular Flow Technologies Ltd. Electronic Equipment/InstrumentsElectronic Technology Vascular Flow Technologies Ltd. develops vascular devices. It offers Spiral Flow Peripheral Vascular Graft, Spiral Flow AV Access Graft, Spiral Laminar Flow, Power of Spiral Laminar Flow and unique design eliminates graft turbulences. The company was founded by Peter Stonebridge, Brian Howlett, Graeme Houston and John B.C. Dick and headquartered in Dundee, the United Kingdom. | Electronic Equipment/Instruments | Chief Executive Officer | |
KAHR Medical Ltd.
![]() KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Sentinext Therapeutics Sdn. Bhd.
![]() Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Biotechnology | Chief Executive Officer | |
Glaxo Laboratories Ltd.
![]() Glaxo Laboratories Ltd. Medical DistributorsDistribution Services Founded in 1929, Glaxo Laboratories Ltd. is a pharmaceutical wholesaler that is part of GSK Plc. The company is based in London, UK. | Medical Distributors | Director of Finance/CFO | |
OMEICOS Therapeutics GmbH
![]() OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Biotechnology | Chairman | |
East Kent Hospitals University NHS Foundation Trust | Hospital/Nursing Management | Director/Board Member | |
Apex Molecular Ltd.
![]() Apex Molecular Ltd. BiotechnologyHealth Technology Apex Molecular Ltd. provides chemistry research and experimental development services. Its services include custom/contract synthesis, targeted library synthesis, process optimisation and supply chain management. The company was founded in 2011 and is headquartered in Cheshire, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Reacta Biotech Ltd.
![]() Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Reacta Biotech Ltd. engages in a biotechnology company. It develops, manufactures, and commercializes oral food challenge materials to pharmaceuticals standards of Good Manufacturing Practice (GMP). The company was founded by Clare Mills, Ashley Woodcock, and Peter McPartland in June 2013 and is headquartered in Deeside, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
FutuRx Ltd.
![]() FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Consultant / Advisor | |
ICONIC LABS PLC | Advertising/Marketing Services | Chairman | |
BioMedx Group, Inc.
![]() BioMedx Group, Inc. Medical SpecialtiesHealth Technology BioMedx Group, Inc. operates as a medical technology company transforming the cosmetic surgery consultation services. The firm engages in product development focus on the modeling and simulation of the human face for aesthetic and facial reconstruction applications. The company was founded by Rudy A. Mazzocchi and is headquartered in Baltimore, MD. | Medical Specialties | Director/Board Member | |
BioMed X GmbH
![]() BioMed X GmbH Miscellaneous Commercial ServicesCommercial Services BioMed X GmbH is an independent research institute that conducts biomedical pre-clinical research projects in the fields of biomedicine, molecular biology, cell biology, and diagnostics. The private company is based in Heidelberg, Germany. The German company sponsors these projects with pharmaceutical partners such as Merck, Boehringer Ingelheim, Johnson & Johnson, AbbVie, and Roche. Talented early-career scientists from all over the world are recruited to work on these projects. The company combines crowdsourcing with local incubation to provide creative solutions to big biomedical research challenges. Each research team has access to state-of-the-art research infrastructure and is guided by experienced mentors from academia and industry. The company was founded in 2013 by Christian Tidona, who has been the CEO since 2013. | Miscellaneous Commercial Services | Director/Board Member | |
BIVICTRIX THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Director/Board Member Founder Director/Board Member | |
Beautiful Information Ltd.
![]() Beautiful Information Ltd. Packaged SoftwareTechnology Services Part of Vitalhub Corp., Beautiful Information Ltd. is a British company that provides real-time information of patient flow solutions. The company is based in Ashford, UK. Beautiful Information was acquired by The Oakgroup (UK) Ltd. on January 27, 2022 for $2.08 million. | Packaged Software | Chairman | |
R&B Underwriting | Chairman | ||
Amarna Therapeutics BV
![]() Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
ACM Biolabs Pte Ltd.
![]() ACM Biolabs Pte Ltd. BiotechnologyHealth Technology ACM Biolabs Pte Ltd. operates as a synthetic biology company which uses its ACM technology platform to allow clients to develop diagnostics, therapeutics and vaccines targeting novel membrane proteins. The company was founded by Madhavan Nallani in 2013 and is headquartered in Singapore. | Biotechnology | Director/Board Member | |
C E Heath Plc | Chief Executive Officer | ||
ASHINGTON INNOVATION PLC | Financial Conglomerates | Chairman | |
Infex Therapeutics Holdings Plc
![]() Infex Therapeutics Holdings Plc Miscellaneous Commercial ServicesCommercial Services Infex Therapeutics Holdings PLC is a British biotechnology company founded in 2022. The company is based in Milton Keynes, UK. The company is engaged in research and experimental development in the field of biotechnology. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistiques
Internationale
Royaume-Uni | 29 |
Allemagne | 6 |
Etats-Unis | 5 |
Pays-Bas | 5 |
Israël | 5 |
Sectorielle
Health Technology | 24 |
Consumer Services | 9 |
Commercial Services | 7 |
Finance | 5 |
Technology Services | 3 |
Opérationnelle
Director/Board Member | 176 |
Corporate Officer/Principal | 55 |
Chairman | 52 |
Chief Executive Officer | 27 |
Independent Dir/Board Member | 19 |
Relations les plus connectées
Insiders | |
---|---|
Jonathan Moulton | 76 |
Frank Armstrong | 41 |
Iain Ross | 41 |
David Lawrence | 29 |
Peter Jackson | 16 |
Michael Breen | 16 |
Bernhard Kirschbaum | 15 |
Peter Presland | 13 |
Norman Molyneux | 9 |
Peter McPartland | 9 |
Christopher Doherty | 8 |
Karl Hård | 7 |
Nicholas Adams | 7 |
Tony Flinn | 7 |
Neil David Murray | 7 |
- Bourse
- Insiders
- Derek Lindsay
- Connexions Sociétés